Just recently going through the ACLS provider manual and noticed that atropine was removed from the updated guidelines for treatments of cardiac arrest with PEA and asystole. There was a brief paragraph that essentially stated the reasoning (paraphrasing) as atropine being found to be of no detriment but also not being proven to be of any benefit in cardiac arrest.
This new algorithm was news to me and caught me by surprise seeing as that I feel like, as anesthesiologists, we should know ACLS better than anyone in the hospital, with the exception of intensivists, and I knew nothing about this. Can anyone elaborate further on why the change (and the data/literature)? Also, was anyone else as surprised by this change as me?
This new algorithm was news to me and caught me by surprise seeing as that I feel like, as anesthesiologists, we should know ACLS better than anyone in the hospital, with the exception of intensivists, and I knew nothing about this. Can anyone elaborate further on why the change (and the data/literature)? Also, was anyone else as surprised by this change as me?